Structure

Physi-Chem Properties

Molecular Weight:  356.11
Volume:  334.109
LogP:  -0.125
LogD:  0.137
LogS:  -1.522
# Rotatable Bonds:  6
TPSA:  145.91
# H-Bond Aceptor:  9
# H-Bond Donor:  5
# Rings:  2
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.323
Synthetic Accessibility Score:  3.748
Fsp3:  0.438
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.777
MDCK Permeability:  6.25475513515994e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.848
Human Intestinal Absorption (HIA):  0.783
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.985

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.309
Plasma Protein Binding (PPB):  59.3663444519043%
Volume Distribution (VD):  0.333
Pgp-substrate:  27.084278106689453%

ADMET: Metabolism

CYP1A2-inhibitor:  0.213
CYP1A2-substrate:  0.061
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.072
CYP2C9-inhibitor:  0.006
CYP2C9-substrate:  0.754
CYP2D6-inhibitor:  0.021
CYP2D6-substrate:  0.201
CYP3A4-inhibitor:  0.113
CYP3A4-substrate:  0.037

ADMET: Excretion

Clearance (CL):  3.323
Half-life (T1/2):  0.887

ADMET: Toxicity

hERG Blockers:  0.058
Human Hepatotoxicity (H-HT):  0.214
Drug-inuced Liver Injury (DILI):  0.119
AMES Toxicity:  0.162
Rat Oral Acute Toxicity:  0.033
Maximum Recommended Daily Dose:  0.009
Skin Sensitization:  0.519
Carcinogencity:  0.04
Eye Corrosion:  0.005
Eye Irritation:  0.199
Respiratory Toxicity:  0.038

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC185778

Natural Product ID:  NPC185778
Common Name*:   Methyl 3-O-Beta-D-Glucopyranosyl-5-Hydroxycinnamate
IUPAC Name:   methyl (E)-3-[3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoate
Synonyms:  
Standard InCHIKey:  ZROOQFAPMUQERH-JGWMVUGPSA-N
Standard InCHI:  InChI=1S/C16H20O9/c1-23-12(19)3-2-8-4-9(18)6-10(5-8)24-16-15(22)14(21)13(20)11(7-17)25-16/h2-6,11,13-18,20-22H,7H2,1H3/b3-2+/t11-,13-,14+,15-,16-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2cc(/C=C/C(=O)OC)cc(c2)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL520439
PubChem CID:   11222008
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14305 Moricandia arvensis Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[15844940]
NPO14305 Moricandia arvensis Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 0.35 mM PMID[479130]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 630.8 ug.mL-1 PMID[479130]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC185778 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9398 High Similarity NPC124149
0.9219 High Similarity NPC12308
0.9185 High Similarity NPC100389
0.9179 High Similarity NPC37468
0.9143 High Similarity NPC478237
0.913 High Similarity NPC297342
0.9118 High Similarity NPC210478
0.9098 High Similarity NPC115022
0.9098 High Similarity NPC294166
0.9084 High Similarity NPC218003
0.9078 High Similarity NPC106138
0.9037 High Similarity NPC157554
0.9037 High Similarity NPC186418
0.9023 High Similarity NPC303422
0.9023 High Similarity NPC165686
0.9023 High Similarity NPC85799
0.9023 High Similarity NPC26080
0.9015 High Similarity NPC262606
0.9008 High Similarity NPC146540
0.8986 High Similarity NPC145319
0.8986 High Similarity NPC157816
0.8978 High Similarity NPC202700
0.8963 High Similarity NPC238243
0.8955 High Similarity NPC49074
0.8951 High Similarity NPC213197
0.8947 High Similarity NPC121376
0.8939 High Similarity NPC295970
0.8936 High Similarity NPC41844
0.8921 High Similarity NPC478239
0.8913 High Similarity NPC186406
0.8905 High Similarity NPC226005
0.8897 High Similarity NPC138350
0.8897 High Similarity NPC3293
0.8897 High Similarity NPC103409
0.8897 High Similarity NPC40664
0.8897 High Similarity NPC165482
0.8897 High Similarity NPC166180
0.8897 High Similarity NPC197723
0.8889 High Similarity NPC188555
0.8889 High Similarity NPC130496
0.8881 High Similarity NPC162093
0.8873 High Similarity NPC93924
0.8873 High Similarity NPC96294
0.8865 High Similarity NPC199928
0.8857 High Similarity NPC292443
0.8824 High Similarity NPC55040
0.8815 High Similarity NPC132895
0.8811 High Similarity NPC283839
0.8811 High Similarity NPC206264
0.8811 High Similarity NPC313334
0.8811 High Similarity NPC90896
0.8811 High Similarity NPC212670
0.8806 High Similarity NPC475067
0.8803 High Similarity NPC52740
0.8794 High Similarity NPC226722
0.8794 High Similarity NPC85624
0.8794 High Similarity NPC138915
0.8777 High Similarity NPC215512
0.8777 High Similarity NPC476442
0.8768 High Similarity NPC212770
0.8768 High Similarity NPC98777
0.8759 High Similarity NPC164857
0.8759 High Similarity NPC104167
0.8759 High Similarity NPC169404
0.8759 High Similarity NPC176186
0.8759 High Similarity NPC203230
0.8759 High Similarity NPC53587
0.8759 High Similarity NPC242028
0.875 High Similarity NPC251981
0.875 High Similarity NPC114740
0.875 High Similarity NPC48863
0.875 High Similarity NPC13745
0.8741 High Similarity NPC169510
0.8741 High Similarity NPC299144
0.8732 High Similarity NPC476865
0.8723 High Similarity NPC232228
0.8723 High Similarity NPC476867
0.8722 High Similarity NPC40377
0.8714 High Similarity NPC140502
0.8699 High Similarity NPC150442
0.8696 High Similarity NPC65530
0.8696 High Similarity NPC59324
0.8696 High Similarity NPC134260
0.8692 High Similarity NPC52097
0.8686 High Similarity NPC470236
0.8676 High Similarity NPC215833
0.8676 High Similarity NPC69513
0.8671 High Similarity NPC296377
0.8671 High Similarity NPC471764
0.8671 High Similarity NPC87950
0.8662 High Similarity NPC476864
0.8662 High Similarity NPC476869
0.8662 High Similarity NPC476866
0.8662 High Similarity NPC476868
0.8657 High Similarity NPC229784
0.8657 High Similarity NPC477294
0.8657 High Similarity NPC97326
0.8657 High Similarity NPC477293
0.8657 High Similarity NPC248355
0.8652 High Similarity NPC242756
0.8643 High Similarity NPC210192
0.8643 High Similarity NPC257095
0.8643 High Similarity NPC89686
0.8643 High Similarity NPC273932
0.8639 High Similarity NPC260604
0.8639 High Similarity NPC299435
0.863 High Similarity NPC472611
0.863 High Similarity NPC289967
0.863 High Similarity NPC472612
0.863 High Similarity NPC215060
0.863 High Similarity NPC476352
0.8615 High Similarity NPC11724
0.8613 High Similarity NPC107478
0.8611 High Similarity NPC140722
0.8611 High Similarity NPC4958
0.8611 High Similarity NPC92054
0.8603 High Similarity NPC470270
0.8603 High Similarity NPC473285
0.8592 High Similarity NPC110063
0.8582 High Similarity NPC475084
0.8582 High Similarity NPC302378
0.8582 High Similarity NPC189115
0.8582 High Similarity NPC232880
0.8582 High Similarity NPC469559
0.8571 High Similarity NPC233559
0.8571 High Similarity NPC246893
0.8571 High Similarity NPC471157
0.8571 High Similarity NPC105827
0.8571 High Similarity NPC310661
0.8561 High Similarity NPC195196
0.854 High Similarity NPC254398
0.8538 High Similarity NPC476872
0.8533 High Similarity NPC160780
0.8533 High Similarity NPC289811
0.8531 High Similarity NPC34927
0.8531 High Similarity NPC34587
0.8531 High Similarity NPC476382
0.8531 High Similarity NPC216819
0.8531 High Similarity NPC262182
0.8531 High Similarity NPC83743
0.8531 High Similarity NPC100998
0.8531 High Similarity NPC287615
0.8531 High Similarity NPC252292
0.8529 High Similarity NPC166168
0.8529 High Similarity NPC219677
0.8521 High Similarity NPC473044
0.8519 High Similarity NPC166040
0.8519 High Similarity NPC307110
0.8519 High Similarity NPC48315
0.8511 High Similarity NPC469661
0.8507 High Similarity NPC156692
0.8507 High Similarity NPC106677
0.8507 High Similarity NPC173150
0.8507 High Similarity NPC140750
0.8507 High Similarity NPC471882
0.8507 High Similarity NPC45224
0.8507 High Similarity NPC476873
0.8507 High Similarity NPC471881
0.8507 High Similarity NPC35288
0.8503 High Similarity NPC470264
0.8496 Intermediate Similarity NPC126991
0.8496 Intermediate Similarity NPC83218
0.8489 Intermediate Similarity NPC26954
0.8489 Intermediate Similarity NPC471719
0.8489 Intermediate Similarity NPC38099
0.8483 Intermediate Similarity NPC187398
0.8483 Intermediate Similarity NPC302989
0.8483 Intermediate Similarity NPC476348
0.8483 Intermediate Similarity NPC83975
0.8478 Intermediate Similarity NPC111635
0.8478 Intermediate Similarity NPC87696
0.8478 Intermediate Similarity NPC471883
0.8477 Intermediate Similarity NPC203020
0.8477 Intermediate Similarity NPC239966
0.8473 Intermediate Similarity NPC226712
0.8472 Intermediate Similarity NPC107120
0.8472 Intermediate Similarity NPC74320
0.8467 Intermediate Similarity NPC245120
0.8467 Intermediate Similarity NPC5423
0.8467 Intermediate Similarity NPC473924
0.8467 Intermediate Similarity NPC1913
0.8462 Intermediate Similarity NPC473045
0.8462 Intermediate Similarity NPC25292
0.8456 Intermediate Similarity NPC472024
0.8456 Intermediate Similarity NPC80600
0.8456 Intermediate Similarity NPC470079
0.8451 Intermediate Similarity NPC65833
0.8451 Intermediate Similarity NPC193722
0.8451 Intermediate Similarity NPC31081
0.8451 Intermediate Similarity NPC278469
0.8451 Intermediate Similarity NPC245219
0.8446 Intermediate Similarity NPC34965
0.8446 Intermediate Similarity NPC183536
0.8444 Intermediate Similarity NPC109275
0.8444 Intermediate Similarity NPC198487
0.844 Intermediate Similarity NPC267291
0.8435 Intermediate Similarity NPC93619
0.8433 Intermediate Similarity NPC252114
0.8429 Intermediate Similarity NPC262328
0.8429 Intermediate Similarity NPC126206

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC185778 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8811 High Similarity NPD1653 Approved
0.8473 Intermediate Similarity NPD1091 Approved
0.8239 Intermediate Similarity NPD7266 Discontinued
0.7987 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7877 Intermediate Similarity NPD1652 Phase 2
0.7857 Intermediate Similarity NPD3027 Phase 3
0.784 Intermediate Similarity NPD6559 Discontinued
0.7817 Intermediate Similarity NPD1613 Approved
0.7817 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7794 Intermediate Similarity NPD422 Phase 1
0.7764 Intermediate Similarity NPD7054 Approved
0.7716 Intermediate Similarity NPD7472 Approved
0.7716 Intermediate Similarity NPD7074 Phase 3
0.7702 Intermediate Similarity NPD3818 Discontinued
0.7692 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD6797 Phase 2
0.7639 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD5124 Phase 1
0.7628 Intermediate Similarity NPD5402 Approved
0.7622 Intermediate Similarity NPD7251 Discontinued
0.7591 Intermediate Similarity NPD3496 Discontinued
0.7584 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD7808 Phase 3
0.7546 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7535 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD7075 Discontinued
0.7516 Intermediate Similarity NPD5403 Approved
0.75 Intermediate Similarity NPD37 Approved
0.7485 Intermediate Similarity NPD7228 Approved
0.7484 Intermediate Similarity NPD6234 Discontinued
0.7468 Intermediate Similarity NPD4965 Approved
0.7468 Intermediate Similarity NPD4967 Phase 2
0.7468 Intermediate Similarity NPD4966 Approved
0.7467 Intermediate Similarity NPD4628 Phase 3
0.7466 Intermediate Similarity NPD6653 Approved
0.7465 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD1358 Approved
0.7432 Intermediate Similarity NPD1551 Phase 2
0.7431 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD4749 Approved
0.7413 Intermediate Similarity NPD4908 Phase 1
0.7397 Intermediate Similarity NPD230 Phase 1
0.7391 Intermediate Similarity NPD7199 Phase 2
0.7389 Intermediate Similarity NPD1934 Approved
0.7386 Intermediate Similarity NPD5401 Approved
0.7372 Intermediate Similarity NPD4380 Phase 2
0.7342 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD8455 Phase 2
0.7342 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD4060 Phase 1
0.7328 Intermediate Similarity NPD290 Approved
0.7321 Intermediate Similarity NPD8312 Approved
0.7321 Intermediate Similarity NPD8313 Approved
0.732 Intermediate Similarity NPD6799 Approved
0.7319 Intermediate Similarity NPD1357 Approved
0.731 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD7685 Pre-registration
0.7303 Intermediate Similarity NPD6190 Approved
0.7296 Intermediate Similarity NPD3817 Phase 2
0.729 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7286 Intermediate Similarity NPD1610 Phase 2
0.7278 Intermediate Similarity NPD6801 Discontinued
0.7267 Intermediate Similarity NPD5762 Approved
0.7267 Intermediate Similarity NPD5763 Approved
0.7266 Intermediate Similarity NPD1778 Approved
0.7256 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD6166 Phase 2
0.7252 Intermediate Similarity NPD3134 Approved
0.7246 Intermediate Similarity NPD1548 Phase 1
0.7246 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD4625 Phase 3
0.7233 Intermediate Similarity NPD7819 Suspended
0.7229 Intermediate Similarity NPD5844 Phase 1
0.7208 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD7843 Approved
0.7183 Intermediate Similarity NPD2982 Phase 2
0.7183 Intermediate Similarity NPD2983 Phase 2
0.7181 Intermediate Similarity NPD7097 Phase 1
0.7171 Intermediate Similarity NPD6674 Discontinued
0.7169 Intermediate Similarity NPD3751 Discontinued
0.7163 Intermediate Similarity NPD3705 Approved
0.7162 Intermediate Similarity NPD447 Suspended
0.7162 Intermediate Similarity NPD4340 Discontinued
0.7153 Intermediate Similarity NPD7157 Approved
0.7153 Intermediate Similarity NPD6671 Approved
0.7151 Intermediate Similarity NPD6843 Phase 3
0.7151 Intermediate Similarity NPD6842 Approved
0.7151 Intermediate Similarity NPD6841 Approved
0.7143 Intermediate Similarity NPD6233 Phase 2
0.7143 Intermediate Similarity NPD2684 Approved
0.7143 Intermediate Similarity NPD3882 Suspended
0.7143 Intermediate Similarity NPD5058 Phase 3
0.7133 Intermediate Similarity NPD3225 Approved
0.7126 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD2801 Approved
0.7124 Intermediate Similarity NPD3750 Approved
0.7113 Intermediate Similarity NPD2981 Phase 2
0.7111 Intermediate Similarity NPD969 Suspended
0.7107 Intermediate Similarity NPD7411 Suspended
0.7105 Intermediate Similarity NPD2424 Discontinued
0.7105 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD1549 Phase 2
0.7103 Intermediate Similarity NPD2861 Phase 2
0.7101 Intermediate Similarity NPD7240 Approved
0.7071 Intermediate Similarity NPD5585 Approved
0.7067 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD1933 Approved
0.7044 Intermediate Similarity NPD6599 Discontinued
0.7039 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD5647 Approved
0.703 Intermediate Similarity NPD3787 Discontinued
0.702 Intermediate Similarity NPD7033 Discontinued
0.7019 Intermediate Similarity NPD1465 Phase 2
0.7007 Intermediate Similarity NPD7095 Approved
0.7006 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.6993 Remote Similarity NPD1608 Approved
0.6993 Remote Similarity NPD9717 Approved
0.6992 Remote Similarity NPD968 Approved
0.6987 Remote Similarity NPD1511 Approved
0.6987 Remote Similarity NPD4357 Discontinued
0.6986 Remote Similarity NPD3018 Phase 2
0.6974 Remote Similarity NPD6100 Approved
0.6974 Remote Similarity NPD6099 Approved
0.6974 Remote Similarity NPD6032 Approved
0.6974 Remote Similarity NPD2935 Discontinued
0.6966 Remote Similarity NPD2797 Approved
0.6966 Remote Similarity NPD1203 Approved
0.6959 Remote Similarity NPD6798 Discontinued
0.6959 Remote Similarity NPD1048 Approved
0.6954 Remote Similarity NPD4536 Approved
0.6954 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6954 Remote Similarity NPD4538 Approved
0.6948 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6943 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6939 Remote Similarity NPD6832 Phase 2
0.6939 Remote Similarity NPD1008 Clinical (unspecified phase)
0.6936 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6933 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6933 Remote Similarity NPD7768 Phase 2
0.6933 Remote Similarity NPD6355 Discontinued
0.6929 Remote Similarity NPD5536 Phase 2
0.6928 Remote Similarity NPD6005 Phase 3
0.6928 Remote Similarity NPD6004 Phase 3
0.6928 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6928 Remote Similarity NPD6002 Phase 3
0.6928 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6918 Remote Similarity NPD3686 Approved
0.6918 Remote Similarity NPD3687 Approved
0.6917 Remote Similarity NPD9697 Approved
0.6913 Remote Similarity NPD4062 Phase 3
0.6901 Remote Similarity NPD4626 Approved
0.6899 Remote Similarity NPD1512 Approved
0.6894 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6879 Remote Similarity NPD9545 Approved
0.6875 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6875 Remote Similarity NPD2231 Phase 2
0.6875 Remote Similarity NPD2235 Phase 2
0.6871 Remote Similarity NPD5353 Approved
0.6871 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6867 Remote Similarity NPD4140 Approved
0.6863 Remote Similarity NPD2796 Approved
0.6861 Remote Similarity NPD228 Approved
0.686 Remote Similarity NPD7549 Discontinued
0.6849 Remote Similarity NPD6362 Approved
0.6846 Remote Similarity NPD3268 Approved
0.6846 Remote Similarity NPD411 Approved
0.6845 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6839 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6835 Remote Similarity NPD3536 Discontinued
0.6835 Remote Similarity NPD2534 Approved
0.6835 Remote Similarity NPD2532 Approved
0.6835 Remote Similarity NPD2533 Approved
0.6831 Remote Similarity NPD5691 Approved
0.6828 Remote Similarity NPD4359 Approved
0.6826 Remote Similarity NPD6232 Discontinued
0.6818 Remote Similarity NPD3656 Approved
0.6818 Remote Similarity NPD291 Approved
0.6812 Remote Similarity NPD5535 Approved
0.6797 Remote Similarity NPD1510 Phase 2
0.6797 Remote Similarity NPD5588 Approved
0.6797 Remote Similarity NPD3748 Approved
0.6797 Remote Similarity NPD5960 Phase 3
0.6795 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6788 Remote Similarity NPD6971 Discontinued
0.6783 Remote Similarity NPD5126 Approved
0.6783 Remote Similarity NPD5125 Phase 3
0.6783 Remote Similarity NPD17 Approved
0.6781 Remote Similarity NPD8651 Approved
0.6774 Remote Similarity NPD7585 Approved
0.6766 Remote Similarity NPD8127 Discontinued
0.6766 Remote Similarity NPD6959 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data